NDC 84149-0102 Jujiafenhuangquan Yindaoshuan

Policresulen Vaginal Suppository Suppository Vaginal - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
84149-0102
Proprietary Name:
Jujiafenhuangquan Yindaoshuan
Non-Proprietary Name: [1]
Policresulen Vaginal Suppository
Substance Name: [2]
Policresulen
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Suppository - A solid body of various weights and shapes, adapted for introduction into the rectal orifice of the human body; they usually melt, soften, or dissolve at body temperature.
Administration Route(s): [4]
  • Vaginal - Administration into the vagina.
  • Labeler Code:
    84149
    Marketing Category: [8]
    UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
    Start Marketing Date: [9]
    03-06-2024
    Listing Expiration Date: [11]
    12-31-2025
    Exclude Flag: [12]
    N
    Code Navigator:

    Code Structure Chart

    Product Details

    What is NDC 84149-0102?

    The NDC code 84149-0102 is assigned by the FDA to the product Jujiafenhuangquan Yindaoshuan which is a human over the counter drug product labeled by Heilongjiang Tianlong Pharmaceutical Co Ltd. The generic name of Jujiafenhuangquan Yindaoshuan is policresulen vaginal suppository. The product's dosage form is suppository and is administered via vaginal form. The product is distributed in a single package with assigned NDC code 84149-0102-3 5 mg in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Jujiafenhuangquan Yindaoshuan?

    【Precaution】1. External use only, should not be taken orally.2. This product should avoid contact with eyes.3. This product will accelerate and enhance the repair process. If the necrotic tissue falls off from the focus, sometimes even a large sheet falls off. Do not panic.4. Stop treatment during menstruation. Avoid sexual life during treatment. Do not use irritating soap to clean the affected area.5. Cotton fabric and leather shall be washed with water immediately before the preparation is dry, when the solution contacting with them.6. Spots on the vaginal suppository are the natural phenomena produced by its matrix, which do not affect the use and efficacy of the drug, nor affect its tolerance.【Medication for pregnant women and lactating women】 During pregnancy, especially in the third trimester, any cervical treatment should be avoided, and the Policresulen suppository is no exception. At this time, the potential harm of the drug to the mother and baby should be fully considered. Although the animal test shows that the drug has no teratogenic effect, the results of the human test have not been obtained. It is unclear whether the milk of lactating women will contain the active ingredient of this medicine.【Children Medication】The safety and efficacy of children patients have not been studied.【Geriatric Medication】The safety and efficacy of elderly patients have not been studied.【Drug Interactions】Policresulen can only be used locally. Since the interaction with other drugs cannot be ruled out, it is avoided to use more than two drugs at the same place at the same time.

    What are Jujiafenhuangquan Yindaoshuan Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".